Navigation Links
Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, August 9
Date:8/1/2011

f Arena's most advanced drug candidate and Arena's focus, goals, strategy, research and development programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, the following: the timing of regulatory review and approval is uncertain; the risk that data and other information related to Arena's research and development programs may not meet safety or efficacy requirements or otherwise be sufficient for regulatory approval; Arena's response to the CRL for the lorcaserin NDA or submission of a Marketing Authorization Application for regulatory approval of lorcaserin may not be submitted when anticipated, if at all; the FDA may request other information prior to or after Arena submits such response or approval of the lorcaserin NDA; unexpected or unfavorable new data; risks related to commercializing new products; Arena's ability to obtain and defend its patents; the timing, success and cost of Arena's research and development programs; results of clinical trials and other studies are subject to different interpretations and may not be predictive of future results; clinical trials and other studies may not proceed at the time or in the manner expected or at all; Arena's ability to obtain adequate funds; risks related to relying on collaborative agreements; the timing and receipt of payments and fees, if any, from collaborators; and satisfactory resolution of pending and any future litigation or other disagreements with others. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking statements are disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looki
'/>"/>
SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Arena Pharmaceuticals Announces Phase 1 Results for APD811 for Pulmonary Arterial Hypertension
2. Meta-Analyses of Phase 3 Trials Show Obese and Overweight Patients Taking Arena Pharmaceuticals Lorcaserin Achieved Statistically Significant Weight Loss
3. Arena Pharmaceuticals Announces First Quarter 2011 Financial Results and Recent Developments
4. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference
5. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, May 10
6. Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Financial Results and Reviews Recent Developments
7. Arena Pharmaceuticals Expands GPR119 Patent Portfolio for Type 2 Diabetes
8. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Friday, March 11
9. Arena Pharmaceuticals Announces Upcoming Departure of Chief Financial Officer
10. Arena Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
11. Arena and Eisai Complete End-of-Review Meeting with FDA for Lorcaserin New Drug Application
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... Medical Services Holdings Limited ("Concord Medical", or the "Company") (NYSE: ... of the largest network of radiotherapy and diagnostic imaging centers ... release its financial results for the second quarter of 2015 ... Management will hold a conference call to discuss the results ... 2015 (8:00 p.m. in Beijing / ...
(Date:8/4/2015)... Md. , Aug. 4, 2015 ... drug-free over-the-counter ActiPatch® Musculoskeletal Pain Therapy medical devices, ... users of its ActiPatch 7-day trial device has ... journal Pain Management http://www.futuremedicine.com/doi/full/10.2217/PMT.15.35 .  ... the survey and submitted an assessment.  ...
(Date:8/4/2015)... Aug. 04, 2015 ... the addition of Jain PharmaBiotech,s new report ... to their offering. This report describes ... veterinary medicine and pharmaceuticals as well as improvement ... important in the application of biotechnology to manage ...
Breaking Medicine Technology:Concord Medical to Report Second Quarter 2015 Financial Results on August 17, 2015 2BioElectronics' Landmark 5,000+ Chronic Pain Patient Study Published in Pain Management Medical Journal 2Animal Biotechnology 2014-2024 - 2015 Technologies, Markets and Companies Analysis 2Animal Biotechnology 2014-2024 - 2015 Technologies, Markets and Companies Analysis 3
... CSA Medical, Inc. announced today that New ... providing Spray Cryotherapy treatment for patients. Dr. Costas ... department of Cardiothoracic Surgery is performing this procedure. ... in the Department of Cardiothoracic Surgery at NYU ...
... 20 Despite Tylenol,s product recalls and plant closure, ... consumers, according to a research study released today. ... and build loyalty to them in the same way ... terms of warmth and competence – and these judgments ...
Cached Medicine Technology:CSA Medical, Inc. Announces 75th Customer 2Study of Brands Shows Tylenol Maintains Consumer Loyalty Despite Recent Quality Challenges 2
(Date:8/4/2015)... ... August 04, 2015 , ... It’s been called “cosmetics ... the customer experience inside Naimie’s Beauty Center in LA. Now MENAJI is part of ... look better. , Naimie’s Beauty Center has been a favorite of makeup artists and ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... the North America IT reseller channel will grow at least 6 percent in ... their 2014 pace and greater than their OEM/vendor partners. , The 2112 ...
(Date:8/4/2015)... ... August 04, 2015 , ... Data2Life , a Tel ... to provide pharmaceutical and healthcare organizations with advanced intelligence on drug effects. The ... regulatory filings (including the FDA and HealthCanada), social media and anonymized clinical electronic ...
(Date:8/4/2015)... ... August 04, 2015 , ... Armadale ... finance, announced the closing of a $118 million FHA-insured loan modification refinancing for ... in Smithfield and Clayton, North Carolina. JHSC is a joint venture of ...
(Date:8/4/2015)... ... ... Updated enrollment data on the top U.S. health plans, as collected by Atlantic ... . The data is free to all registered users to AISHealth.com. Based on the ... website’s “Data” section include:, , Top 25 U.S. Health Plans, ...
Breaking Medicine News(10 mins):Health News:MENAJI Shines in Make-Up Mecca for Stars 2Health News:The 2112 Group Forecasts North America IT Channel to Grow At Least 6% in 2015 2Health News:The 2112 Group Forecasts North America IT Channel to Grow At Least 6% in 2015 3Health News:Data2Life Announces New System for Advance Intelligence on Drug Events 2Health News:Data2Life Announces New System for Advance Intelligence on Drug Events 3Health News:Armadale Capital Inc. Refinances $118 Million for Johnston Health Services Corporation 2Health News:Armadale Capital Inc. Refinances $118 Million for Johnston Health Services Corporation 3Health News:Atlantic Information Services Website Offers Up-to-Date U.S. Health Plan Enrollment Data 2
... found that a woman,s partner status influenced her interest ... women both with and without sexual partners showed little ... when considering such measures as masculinity and attractiveness. However, ... more time evaluating photos of men, demonstrating a greater ...
... Inc. ("Versus" or the "Company") (OTC Pink Sheets: VSTI) announced ... 30, 2009, a 20% decrease compared to revenues of $1,424,000 ... for the six months ended April 30, 2009 were $2,750,000, ... 2008, a 3.5% decrease. Versus, quarterly revenues can vary ...
... N.C., MAY 28 Family Health International announced today ... grant from the Bill & Melinda Gates Foundation. ... project led by David C. Sokal, M.D., studying a ... breastfeeding.Dr. Sokal,s project is one of 81 grants announced ...
... When faced with a terminal illness, African-American seniors ... they would want life-prolonging treatments, according to a University ... June issue of the Journal of General Internal ... E. Barnato, M.D., M.P.H., associate professor of medical, clinical ...
... Innovative Public/Private Partnership Launches at State Legislative Hearing TRENTON, ... shortage that could cause grave harm to patient care ... the New Jersey Chamber of Commerce Foundation today announced ... Jersey will have the nursing workforce it needs to ...
... Math & Science Classes for High School Students as Gateways to High-Tech ... ... for patients with a SynCardia temporary CardioWest™ Total Artificial Heart , ... physician or nurse. This high-tech career impacts the lives of many and ...
Cached Medicine News:Health News:Partner status influences women's interest in men 2Health News:Versus Technology Announces Second Quarter Results 2Health News:Versus Technology Announces Second Quarter Results 3Health News:Versus Technology Announces Second Quarter Results 4Health News:Versus Technology Announces Second Quarter Results 5Health News:Versus Technology Announces Second Quarter Results 6Health News:Versus Technology Announces Second Quarter Results 7Health News:Family Health International Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research Project Led by David Sokal, M.D. 2Health News:Family Health International Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research Project Led by David Sokal, M.D. 3Health News:Family Health International Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research Project Led by David Sokal, M.D. 4Health News:Blacks more likely to opt for life-sustaining measures at end of life 2Health News:$22 Million Initiative Aims to Reverse New Jersey's Nurse Faculty Shortage, Avert Health Care Crisis 2Health News:$22 Million Initiative Aims to Reverse New Jersey's Nurse Faculty Shortage, Avert Health Care Crisis 3Health News:$22 Million Initiative Aims to Reverse New Jersey's Nurse Faculty Shortage, Avert Health Care Crisis 4Health News:$22 Million Initiative Aims to Reverse New Jersey's Nurse Faculty Shortage, Avert Health Care Crisis 5Health News:New Video Series Spotlights Role of Biomedical Engineers in Caring for Total Artificial Heart Patients 2
Inquire...
Inquire...
Premier pouches provide the ultimate in skin protection with our long wearing Flextend skin barriers and superior comfort with our soft and silky ComfortWear panels....
... APTT-based kit for the screening of factor-V-related ... of the test for the factor V:Q506 ... plasma with an excess of V-DEF Plasma ... to discriminate between heterozygous and homozygous factor ...
Medicine Products: